The Imaging Market Guide
This comprehensive audit is the industry's premier source of conventional x-ray, CT scanning, MRI, ultrasound, nuclear medicine and cardiac cath lab procedure volumes, with iodinated contrast agent and radiopharmaceutical usage information in hospital and non-hospital settings. Geographic coverage includes the U.S., Italy, Germany, France, U.K., Spain, China, Japan and Korea. The information in this database is collected directly from end users – technologists, managers and supervisors working in hospital radiology departments, hospital cardiology departments, vascular labs, cardiac cath labs, special procedure areas, free-standing imaging centers and private cardiologists' offices. Updated each March and September.
Download brochure
The Angiography Market Guide
A supplement to the Imaging Market Guide designed to capture the nuances of the angiography market, including CT angiography (CTA), MR angiography (MRA) and x-ray angiography. This audit provides procedure volumes for the various anatomical categories as well as patient demographics, clinical reason for performing the procedure, referring physician specialty, site delineation, enhancement agent name and dosing, pressure injector use and magnet strength. Published in March and September.
Download brochure
The Myocardial Perfusion Study Market Guide
A supplement to the Imaging Market Guide that captures the nuances of this growing nuclear cardiology procedure, including quantitative delineation of the various thallium, Cardiolite® and Myoview® protocol details, patient demographics and pharmacologic stress agent usage. Published in March and September.
Download brochure
The Myocardial Perfusion Study Monthly Monitor
A monthly syndicated audit designed to track the number of nuclear myocardial perfusion tests performed in hospital and non-hospital settings. For each study month, this audit provides projections of myocardial perfusion studies performed with each of the various radiopharmaceutical products. Projections are also provided for the number of studies involving pharmacologic stressing with intravenous adenosine, intravenous dipyridamole, intravenous regadenoson and intravenous dobutamine. Available 30 days after the end of each study month.
The Echocardiography Market Guide
A supplement to the Imaging Market Guide designed to monitor the impact of ultrasound contrast agents on this growing and dynamic market. This audit provides procedure volumes for the various types of echocardiographies, patient demographics, clinical reason for performing the procedure, referring physician specialty, site delineation and contrast agent/pharmacologic stressor detail. Published in March and September.
Download brochure
The Echocardiography Monthly Monitor
A monthly syndicated audit of echocardiography procedures, ultrasound contrast agents and pharmacologic stress agents used in hospitals and office-based cardiology settings. The study quantifies echocardiography procedure volumes on a national scale, split by type of echo, contrast/non-contrast, type of contrast and stressing method where applicable. Available 30 days after the end of each study month.
The Contrast Package Market Guide
A syndicated audit that quantitatively characterizes the various package types and sizes used for iodinated contrast agents and MRI enhancement agents. Published in March and September.
Download brochure
The Non-Contrast CT & MR Patient Study
A syndicated study that provides A syndicated study that provides a clinical summary of non-contrast CT and MR patients, including patient demographics, referring physician specialties and reason for procedure. Published in March and September.
Download brochure